Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart Failure

Wednesday, July 27, 2022 1 min read

Key Takeaway: Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart Failure

Full Press Release Details

Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart Failure.